Walkner Condon Financial Advisors LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Walkner Condon Financial Advisors LLC
- $459 Million
- Q2 2024
A detailed history of Walkner Condon Financial Advisors LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Walkner Condon Financial Advisors LLC holds 21,976 shares of DNA stock, worth $124,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,976
Previous 21,976
-0.0%
Holding current value
$124,164
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$808 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$785 Million0.0% of portfolio
-
Baillie Gifford & CO134MShares$760 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$395 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$237 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $7.28B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...